GLP-1 · TZP-001

TIRZEPATIDE

Dual-agonist metabolic recalibration.

A next-generation GLP-1/GIP dual agonist engineered for body recomposition, glucose modulation, and appetite mastery.

Protocol

2.5–15mg weekly

Investment

Mounjaro 30mg £65 , PEN £100

Expected Outcomes

What the molecule delivers.

Profound appetite suppression

Accelerated fat loss

Glycemic control

Energy stability

The triple-agonist apex.